Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
The Sickle Cell Disease Partnership is a multi-sector collaboration of healthcare stakeholders committed to advancing actionable federal healthcare policies that will improve the lives of patients living with Sickle Cell Disease.
The Partnership’s main objective is to work collaboratively across the Sickle Cell Disease community to translate the recommendations of the National Academies’ foundational report into legislative and administrative actions in Congress and the Executive Branch. Their vision is a day when every individual with Sickle Cell Disease in the United States lives to his or her fullest potential because the individual has timely, sustained access to high-quality, equitable, coordinated care and treatment.
Related Content
-
Sickle Cell Anemia Treatment & ManagementThe National Institutes of Health advise...
-
65th American Society of Hematology (ASH) Annual Meeting & ExpositionThe 65th ASH Annual Meeting and Expositi...
-
First World Cord Blood Day on Nov. 15 to Highlight Cord Blood Uses, Stem Cell ResearchThe inaugural World Cord Blood Day on No...
-
Sickle Cell Center of Southern LouisianaThe Tulane University Sickle Cell Center...
-
Kids with sickle cell disease aren’t receiving key vaccines, Michigan study findsA significant proportion of children w...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
-
2023 NHLBI Annual Sickle Cell Disease Research MeetingSave the Date for the NHLBI Annual Sickl...